Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1973 1
1986 1
1988 1
2000 1
2001 1
2003 2
2004 2
2005 2
2007 3
2008 1
2009 1
2010 2
2013 3
2014 2
2015 5
2016 4
2017 9
2018 7
2019 9
2020 11
2021 8
2022 7
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators. Dimopoulos MA, et al. Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26671818 Free article. Clinical Trial.
Lateral Femoral Cutaneous Nerve Angiomyoma.
Mugge L, Dang DD, Chandela S. Mugge L, et al. Cureus. 2021 Oct 12;13(10):e18726. doi: 10.7759/cureus.18726. eCollection 2021 Oct. Cureus. 2021. PMID: 34790481 Free PMC article.
[Cutaneous melanoma].
Eigentler TK, Mügge LO, Bembenek A, Garbe C. Eigentler TK, et al. Among authors: mugge lo. Hautarzt. 2007 Oct;58(10):885-97; quiz 898. doi: 10.1007/s00105-007-1418-6. Hautarzt. 2007. PMID: 17973138 German.
Current treatment options in dermatofibrosarcoma protuberans.
Lemm D, Mügge LO, Mentzel T, Höffken K. Lemm D, et al. Among authors: mugge lo. J Cancer Res Clin Oncol. 2009 May;135(5):653-65. doi: 10.1007/s00432-009-0550-3. Epub 2009 Feb 10. J Cancer Res Clin Oncol. 2009. PMID: 19205737 Review.
HAX-1 regulates SERCA2a oxidation and degradation.
Bidwell PA, Liu GS, Nagarajan N, Lam CK, Haghighi K, Gardner G, Cai WF, Zhao W, Mugge L, Vafiadaki E, Sanoudou D, Rubinstein J, Lebeche D, Hajjar R, Sadoshima J, Kranias EG. Bidwell PA, et al. Among authors: mugge l. J Mol Cell Cardiol. 2018 Jan;114:220-233. doi: 10.1016/j.yjmcc.2017.11.014. Epub 2017 Nov 21. J Mol Cell Cardiol. 2018. PMID: 29169992 Free PMC article.
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Clinical Trial.
Adapting Clinical Practice of Thrombolysis for Acute Ischemic Stroke Beyond 4.5 Hours: A Review of the Literature.
Simpkins AN, Tahsili-Fahadan P, Buchwald N, De Prey J, Farooqui A, Mugge LA, Ranasinghe T, Senetar AJ, Echevarria FD, Alvi MM, Wu O. Simpkins AN, et al. Among authors: mugge la. J Stroke Cerebrovasc Dis. 2021 Nov;30(11):106059. doi: 10.1016/j.jstrokecerebrovasdis.2021.106059. Epub 2021 Aug 28. J Stroke Cerebrovasc Dis. 2021. PMID: 34464927 Review.
82 results